首页> 外文期刊>Southern Medical Journal >Endobronchial ultrasound transbronchial needle aspiration in mediastinal and hilar lymphadenopathies
【24h】

Endobronchial ultrasound transbronchial needle aspiration in mediastinal and hilar lymphadenopathies

机译:纵隔和肺门淋巴腺病的支气管内超声经支气管针吸

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Endobronchial ultrasound (EBUS)-transbronchial needle aspiration (TBNA) is a relatively noninvasive technique that allows sampling of mediastinal and hilar lymph nodes or masses under real-time and direct visualization, overcoming some of the problems associated with mediastinoscopy and blind TBNA. The goal of this study was to evaluate the yield of this technique in patients with and without malignant disease in a newly started EBUS program involving physicians not previously fully trained in interventional pulmonology. Methods: Between March 2010 and July 2011, 43 patients with enlarged lymph nodes (>1 cm on short axis) on chest computed tomography who underwent EBUS-TBNA were included in the study. Nondiagnostic results were confirmed with mediastinoscopy. The sensitivity, specificity, positive predictive value and negative predictive value of the technique were assessed. Results: Among the 43 patients who underwent EBUS-TBNA, a correct diagnosis was made in 39 of the 43 patients (91%). The sensitivity, specificity, positive predictive value, and negative predictive values were 89%, 100%, 100%, and 67%, respectively. The success rate, complication rate, and 30-day mortality were 91%, 0%, and 0%, respectively. Conclusions: EBUS-TBNA is a safe and effective approach with high diagnostic yield and minimal complications for diagnosing and staging of mediastinal/hilar lymph nodes. Satisfactory results can be obtained immediately by pulmonologists experienced in conventional bronchoscopy with the provision of additional training on the technique.
机译:目的:支气管内超声(EBUS)-经支气管针吸术(TBNA)是一种相对无创的技术,可以实时,直接可视化地取样纵隔和肺门淋巴结或肿块,从而克服了与纵隔镜和盲目的TBNA相关的一些问题。这项研究的目的是在一项新的EBUS计划中评估该技术在有无恶性疾病患者中的疗效,该计划由尚未接受过介入肺病学全面培训的医师组成。方法:在2010年3月至2011年7月之间,对43例行EBUS-TBNA的胸部CT淋巴结肿大(短轴> 1 cm)进行了研究。纵隔镜检查证实了非诊断结果。评估了该技术的敏感性,特异性,阳性预测值和阴性预测值。结果:在接受EBUS-TBNA的43例患者中,有43例中的39例(91%)被正确诊断。敏感性,特异性,阳性预测值和阴性预测值分别为89%,100%,100%和67%。成功率,并发症发生率和30天死亡率分别为91%,0%和0%。结论:EBUS-TBNA是诊断和分期纵隔/肺门淋巴结转移的一种安全有效的方法,诊断率高且并发症少。传统的支气管镜检查经验丰富的肺科医生可以立即获得令人满意的结果,并提供有关该技术的额外培训。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号